ID: ALA50385

Max Phase: Preclinical

Molecular Formula: C11H16O6

Molecular Weight: 244.24

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC1=C(OC)C(C2COC(C)(C)O2)OC1=O

Standard InChI:  InChI=1S/C11H16O6/c1-11(2)15-5-6(17-11)7-8(13-3)9(14-4)10(12)16-7/h6-7H,5H2,1-4H3

Standard InChI Key:  WYLJAFOQULODLP-UHFFFAOYSA-N

Associated Targets(non-human)

Alpha-amylase 16 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 244.24Molecular Weight (Monoisotopic): 244.0947AlogP: 0.57#Rotatable Bonds: 3
Polar Surface Area: 63.22Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.57CX Basic pKa: CX LogP: 0.01CX LogD: 0.01
Aromatic Rings: 0Heavy Atoms: 17QED Weighted: 0.68Np Likeness Score: 2.09

References

1. Abell AD, Ratcliffe MJ, Gerrard J..  (1998)  Ascorbic acid-based inhibitors of alpha-amylases.,  (13): [PMID:9873419] [10.1016/s0960-894x(98)00298-4]

Source